首页 > 最新文献

Acta Gastroenterologica Latinoamericana最新文献

英文 中文
[Precision Medicine in the Primary and Secondary Prevention of Gastric Cancer]. 【精准医学在胃癌一级和二级预防中的应用】。
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.349
Irina Luzko, Patricio Medel-Jara, Joan Llach, Diego Reyes, Leticia Moreira, Arnoldo Riquelme

Gastric cancer is one of the most frequent cancers worldwide. It has a poor prognosis associated with late-stage diagnosis, that significantly decreases overall survival. This highlights the importance of prevention and early detection to improve the clinical course of patients. Prevention and early diagnosis of gastric cancer perfectly exemplify the model of precision medicine, a healthcare approach that seeks to place the burden more on the individual than on the general population. This requires not only a comprehensive knowledge of the disease but also the identification of individual factors and the understanding of genetic, molecular and environmental differences, which are key to the development of much more personalized treatment strategies. With this approach, in gastric cancer prevention the subject is always at the center, the measures focus directly on the individual and, secondarily, lead to the optimization of the use of resources. This review briefly discusses primary prevention strategies for gastric cancer based on detection and eradication of Helicobacter pylori and, on the other hand, describes some of the most promising biomarkers for the detection and diagnosis of early gastric cancer identified in blood, saliva, urine, feces, and gastric juice, all of which are components of potential secondary prevention measures.

胃癌是世界上最常见的癌症之一。它的预后较差,与晚期诊断相关,这显著降低了总生存率。这突出了预防和早期发现对改善患者临床病程的重要性。胃癌的预防和早期诊断完美地体现了精准医学的模式,这是一种旨在将负担更多地放在个人身上而不是一般人群身上的医疗保健方法。这不仅需要对疾病有全面的了解,还需要确定个体因素,了解遗传、分子和环境差异,这是制定更加个性化的治疗策略的关键。通过这种方法,在胃癌预防中始终以主体为中心,措施直接针对个体,其次导致资源的优化利用。本文简要讨论了基于幽门螺杆菌检测和根除的胃癌一级预防策略,并介绍了在血液、唾液、尿液、粪便和胃液中检测和诊断早期胃癌的一些最有前途的生物标志物,这些生物标志物都是潜在的二级预防措施的组成部分。
{"title":"[Precision Medicine in the Primary and Secondary Prevention of Gastric Cancer].","authors":"Irina Luzko, Patricio Medel-Jara, Joan Llach, Diego Reyes, Leticia Moreira, Arnoldo Riquelme","doi":"10.52787/agl.v53i3.349","DOIUrl":"10.52787/agl.v53i3.349","url":null,"abstract":"<p><p>Gastric cancer is one of the most frequent cancers worldwide. It has a poor prognosis associated with late-stage diagnosis, that significantly decreases overall survival. This highlights the importance of prevention and early detection to improve the clinical course of patients. Prevention and early diagnosis of gastric cancer perfectly exemplify the model of precision medicine, a healthcare approach that seeks to place the burden more on the individual than on the general population. This requires not only a comprehensive knowledge of the disease but also the identification of individual factors and the understanding of genetic, molecular and environmental differences, which are key to the development of much more personalized treatment strategies. With this approach, in gastric cancer prevention the subject is always at the center, the measures focus directly on the individual and, secondarily, lead to the optimization of the use of resources. This review briefly discusses primary prevention strategies for gastric cancer based on detection and eradication of Helicobacter pylori and, on the other hand, describes some of the most promising biomarkers for the detection and diagnosis of early gastric cancer identified in blood, saliva, urine, feces, and gastric juice, all of which are components of potential secondary prevention measures.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"241-254"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hepatocellular Carcinoma: Epidemiological Reality in Tucumán, Argentine Northwest]. [肝细胞癌:阿根廷西北部Tucumán的流行病学现状]。
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.337
Fernando Buabse, Felipe Palazzo, Ana Palazzo, Dolores Murga, Daniela Perez, Moira Zunino, Claudia Gadea, Carlos Garrocho, Juan José Rodríguez, Rodrigo Segovia, Analía Soria, Pablo Berarducchi, Iris Aybar, Marcela Ortiz Mayor, Carmen Seoane, Nancy Soria, Daniela Lionetti, Marcelo López Avellaneda, Germán Alanís, Marcelo Ferraro, Santiago Villavicencio, Roxana González

Introduction: Hepatocellular carcinoma is the most common primary liver tumor (80 to 90%). It is the sixth most frequent tumor and the third that causes the most cancer-related deaths. 85% occurs in Asia and Africa. In Latin America and Argentina, it is not fully represented in the literature due to the socio-economic reality. Most hepatocellular carcinomas present on the basis of cirrhosis.

Objective: To characterize the pidemiology of hepatocellular carcinoma in Tucumán, Argentina.

Material and method: A descriptive, multicentric, study of both public and private activity in the province was carried out. Based on international guidelines, diagnosis and treatment of patients with hepatocellular carcinoma were carried out.

Results: There were 328 patients, with 109 (33.23%) women and 219 (66.76%) men. Of these patients, 294 (89.6%) had cirrhotic liver. The 5-year survival was 6.09% (n:20/328) in stage A and 0.914% (n:3/328) in stage B.

Conclusion: The epidemiology of hepatocellular carcinoma in Tucumán, Argentina was updated; coinciding with the literature. From the epidemiological point of view it showed; a higher prevalence of the disease in males than in females; that stage D at the time of diagnosis was the most prevalent; and that the majority of patients suffered from previous liver diseases.

肝细胞癌是最常见的原发性肝脏肿瘤(80% ~ 90%)。它是第六种最常见的肿瘤,也是导致癌症相关死亡人数最多的第三种肿瘤。85%发生在亚洲和非洲。在拉丁美洲和阿根廷,由于社会经济现实,它在文献中没有得到充分体现。大多数肝细胞癌以肝硬化为基础。目的:了解阿根廷Tucumán地区肝细胞癌的流行病学特征。材料和方法:对该省的公共和私人活动进行了描述性、多中心的研究。根据国际指南,对肝细胞癌患者进行诊断和治疗。结果:328例患者中,女性109例(33.23%),男性219例(66.76%)。其中294例(89.6%)为肝硬化。A期5年生存率为6.09% (n:20/328), b期5年生存率为0.914% (n:3/328)。结论:阿根廷Tucumán肝细胞癌流行病学资料更新;与文献相符。从流行病学的角度来看;该疾病在男性中的患病率高于女性;诊断时的D阶段最为普遍;而且大多数患者以前都患有肝脏疾病。
{"title":"[Hepatocellular Carcinoma: Epidemiological Reality in Tucumán, Argentine Northwest].","authors":"Fernando Buabse, Felipe Palazzo, Ana Palazzo, Dolores Murga, Daniela Perez, Moira Zunino, Claudia Gadea, Carlos Garrocho, Juan José Rodríguez, Rodrigo Segovia, Analía Soria, Pablo Berarducchi, Iris Aybar, Marcela Ortiz Mayor, Carmen Seoane, Nancy Soria, Daniela Lionetti, Marcelo López Avellaneda, Germán Alanís, Marcelo Ferraro, Santiago Villavicencio, Roxana González","doi":"10.52787/agl.v53i3.337","DOIUrl":"10.52787/agl.v53i3.337","url":null,"abstract":"<p><strong>Introduction: </strong>Hepatocellular carcinoma is the most common primary liver tumor (80 to 90%). It is the sixth most frequent tumor and the third that causes the most cancer-related deaths. 85% occurs in Asia and Africa. In Latin America and Argentina, it is not fully represented in the literature due to the socio-economic reality. Most hepatocellular carcinomas present on the basis of cirrhosis.</p><p><strong>Objective: </strong>To characterize the pidemiology of hepatocellular carcinoma in Tucumán, Argentina.</p><p><strong>Material and method: </strong>A descriptive, multicentric, study of both public and private activity in the province was carried out. Based on international guidelines, diagnosis and treatment of patients with hepatocellular carcinoma were carried out.</p><p><strong>Results: </strong>There were 328 patients, with 109 (33.23%) women and 219 (66.76%) men. Of these patients, 294 (89.6%) had cirrhotic liver. The 5-year survival was 6.09% (n:20/328) in stage A and 0.914% (n:3/328) in stage B.</p><p><strong>Conclusion: </strong>The epidemiology of hepatocellular carcinoma in Tucumán, Argentina was updated; coinciding with the literature. From the epidemiological point of view it showed; a higher prevalence of the disease in males than in females; that stage D at the time of diagnosis was the most prevalent; and that the majority of patients suffered from previous liver diseases.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"283-290"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500195/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chronic Intestinal Pseudo-Obstruction Associated with Type A Intestinal Neuronal Dysplasia]. [慢性肠假性梗阻与A型肠神经元发育不良相关]。
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.317
Josué Vázquez Arizmendi, Ulises Palacios Morejón, Brenda Martínez Luna, Carlos Domínguez Alvarez, Orlando Zamora Santana, Daniela Ariza Acuña

Introduction: Chronic intestinal pseudo-obstruction is a clinical entity with multiple causes. One of them is intestinal neuronal dysplasia, a rare disease with two subtypes: A and B.

Objective: To present a clinical case of a patient diagnosed with idiopathic gastroparesis associated with type A intestinal neuronal dysplasia.

Clinical case: A 30-year-old female patient with a diagnosis of idiopathic gastroparesis of a long evolution, with multiple hospitalizations and significant weight loss. She developed a aorto-mesenteric compass syndrome that was treated surgically with partial and temporary improvement. A jejunostomy was performed for feeding when symptoms recurred. During this surgical procedure, gastric and jejunal biopsies were performed and a diagnosis of intestinal neuronal dysplasia type A was made.

Conclusion: In the presence of symptoms of intestinal pseudo-obstruction or a diagnosis of idiopathic gastroparesis, it is necessary to consider the involvement of the gastrointestinal plexus. Obtaining an adequate tissue sample and evaluating it with appropriate techniques is of paramount importance to diagnosing the neurogenic etiology of the entity.

慢性假性肠梗阻是一种多病因的临床症状。其中之一是肠道神经元发育不良,这是一种罕见的疾病,有a型和b型两种亚型。目的:报告1例诊断为特发性胃轻瘫合并a型肠道神经元发育不良的患者的临床病例。临床病例:30岁女性,诊断为长期发展的特发性胃轻瘫,多次住院,体重明显下降。她出现了主动脉-肠系膜罗经综合征,手术治疗部分和暂时改善。症状复发时行空肠造口术喂养。在手术过程中,进行了胃和空肠活检,并诊断为a型肠神经元发育不良。结论:在出现假性肠梗阻症状或诊断为特发性胃轻瘫时,有必要考虑胃肠道神经丛的受累。获得足够的组织样本并使用适当的技术对其进行评估对于诊断该实体的神经源性病因至关重要。
{"title":"[Chronic Intestinal Pseudo-Obstruction Associated with Type A Intestinal Neuronal Dysplasia].","authors":"Josué Vázquez Arizmendi, Ulises Palacios Morejón, Brenda Martínez Luna, Carlos Domínguez Alvarez, Orlando Zamora Santana, Daniela Ariza Acuña","doi":"10.52787/agl.v53i3.317","DOIUrl":"10.52787/agl.v53i3.317","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic intestinal pseudo-obstruction is a clinical entity with multiple causes. One of them is intestinal neuronal dysplasia, a rare disease with two subtypes: A and B.</p><p><strong>Objective: </strong>To present a clinical case of a patient diagnosed with idiopathic gastroparesis associated with type A intestinal neuronal dysplasia.</p><p><strong>Clinical case: </strong>A 30-year-old female patient with a diagnosis of idiopathic gastroparesis of a long evolution, with multiple hospitalizations and significant weight loss. She developed a aorto-mesenteric compass syndrome that was treated surgically with partial and temporary improvement. A jejunostomy was performed for feeding when symptoms recurred. During this surgical procedure, gastric and jejunal biopsies were performed and a diagnosis of intestinal neuronal dysplasia type A was made.</p><p><strong>Conclusion: </strong>In the presence of symptoms of intestinal pseudo-obstruction or a diagnosis of idiopathic gastroparesis, it is necessary to consider the involvement of the gastrointestinal plexus. Obtaining an adequate tissue sample and evaluating it with appropriate techniques is of paramount importance to diagnosing the neurogenic etiology of the entity.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"309-313"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of Hemospray® in Upper Gastrointestinal Bleeding due to Gastric Ischemia]. [止血喷雾®在胃缺血上消化道出血中的应用]。
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.310
Manuel Alejandro Mahler, Florencia Soldano Malvar, Tomás Manuel Pérez, Juan Eduardo Pizzala, Sebastián Durán, María Del Pilar Mancini, Fernando Giménez, Dante Manazzoni, Víctor Hugo Abecia, Mariano Marcolongo

We present a case of a patient with a history of unresec-table pancreatic adenocarcinoma who required biliodigestive diversion surgery with Roux-en-Y reconstruction. Due to the presence of portal cavernomatosis, and recurrent episodes of upper gastrointestinal bleeding, gastric devascularization surgery was performed. The patient experienced an initial episode of gastrointestinal bleeding with cardiopulmonary arrest as a complication. After resuscitation, an upper gastrointestinal endoscopy was performed which showed a visible vessel at the gastroenteroanastomosis; a hemostatic clip was placed, and the bleeding stopped. After 72 hours, the patient presented a new episode of hematemesis which led to another upper gastrointestinal endoscopy revealing an area of congestive, friable mucosa with deposits of fibrin and profuse bleeding on the greater gastric curvature; the suspected diagnosis was ischemic gastropathy This area had been recently evaluated by endoscopy and had shown normal characteristics. Endoscopic treatment was performed using TC-325 hemostatic powder (Hemospray ® , Cook), and the bleeding stopped. The patient responded well to the applied treatment and had a favorable outcome.

我们提出一个病例,病人的历史,不可切除的胰腺腺癌谁需要胆道消化转移手术与Roux-en-Y重建。由于存在门脉海绵状瘤病和反复发作的上消化道出血,进行了胃断流手术。患者经历了胃肠道出血的初始发作,并发心肺骤停。复苏后,进行上消化道内镜检查,发现胃肠吻合处可见血管;放上止血夹,血就止住了。72小时后,患者再次出现呕血,再次进行上消化道内窥镜检查,发现胃大弯曲处充血、易碎的粘膜区有纤维蛋白沉积和大量出血;怀疑诊断为缺血性胃病,该区域最近经内镜检查,显示正常特征。使用TC-325止血粉(haemspray®,Cook)进行内镜治疗,出血停止。患者对应用治疗反应良好,预后良好。
{"title":"[Use of Hemospray<sup>®</sup> in Upper Gastrointestinal Bleeding due to Gastric Ischemia].","authors":"Manuel Alejandro Mahler, Florencia Soldano Malvar, Tomás Manuel Pérez, Juan Eduardo Pizzala, Sebastián Durán, María Del Pilar Mancini, Fernando Giménez, Dante Manazzoni, Víctor Hugo Abecia, Mariano Marcolongo","doi":"10.52787/agl.v53i3.310","DOIUrl":"10.52787/agl.v53i3.310","url":null,"abstract":"<p><p>We present a case of a patient with a history of unresec-table pancreatic adenocarcinoma who required biliodigestive diversion surgery with Roux-en-Y reconstruction. Due to the presence of portal cavernomatosis, and recurrent episodes of upper gastrointestinal bleeding, gastric devascularization surgery was performed. The patient experienced an initial episode of gastrointestinal bleeding with cardiopulmonary arrest as a complication. After resuscitation, an upper gastrointestinal endoscopy was performed which showed a visible vessel at the gastroenteroanastomosis; a hemostatic clip was placed, and the bleeding stopped. After 72 hours, the patient presented a new episode of hematemesis which led to another upper gastrointestinal endoscopy revealing an area of congestive, friable mucosa with deposits of fibrin and profuse bleeding on the greater gastric curvature; the suspected diagnosis was ischemic gastropathy This area had been recently evaluated by endoscopy and had shown normal characteristics. Endoscopic treatment was performed using TC-325 hemostatic powder (Hemospray <sup>®</sup> , Cook), and the bleeding stopped. The patient responded well to the applied treatment and had a favorable outcome.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"320-323"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease. 利福昔明在非酒精性脂肪性肝病实验模型中通过调节微生物群预防肝细胞癌的潜在有益作用
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.329
Jéssica Tonin Ferrari, Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Themis Reverbel da Silveira, Carlos Thadeu Schmidt Cerski, Erica Tozawa, Cláudia P Oliveira, Mário Reis Álvares-da-Silva, Carolina Uribe-Cruz

Aim: To evaluate the effects of rifaximin through microbiota modulation in a model of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease.

Methods: Three groups of 8 adult male Sprague-Dawley rats each were divided as follows: the HCC group: rats fed a high-fat and choline-deficient diet plus diethylnitrosamine as a carcinogen, the hepatocellular carcinoma treated group: rats fed a high-fat and choline-deficient diet plus diethylnitrosamine and treated with rifaximin and the control group: animals fed standard diet and water. The rats were euthanized after 16 weeks. We performed analyses of liver pathology for non-alcoholic fatty liver disease severity and cancer grading, gene expression in intestinal and hepatic tissues and fecal microbiota.

Results: All animals in the hepatocellular carcinoma group had non-alcoholic fatty liver disease and developed hepatocellular carcinoma lesions. Rifaximin animals showed less intense non-alcoholic fatty liver disease (assessed by non-alcoholic fatty liver disease activity score [NAS]) compared to the hepatocellular carcinoma group. Both the hepatocellular carcinoma and hepatocellular carcinoma + rifaximin groups showed areas of fibrosis as assessed by picrosirius red. Three animals in the rifaximin group did not develop cancerous lesions. Gut microbiota analyses revealed differences in diversity and composition in the control group vs hepatocellular carcinoma and rifaximin groups. Twelve differentially abundant genera were identified between the hepatocellular carcinoma and rifaximin groups. In the rifaximin group, gene expression of intestinal tight junctions decreased.

Conclusions: In a rodent model of non-alcoholic fatty liver disease-related hepatocellular carcinoma, rifaximin reduces the histological severity of non-alcoholic fatty liver disease and the occurrence of hepatocellular carcinoma, probably by modulating the gut microbiota independently of markers of intestinal permeability.

目的:评价利福昔明在非酒精性脂肪性肝病继发肝细胞癌模型中通过菌群调节的作用。方法:将成年雄性Sprague-Dawley大鼠分成3组,每组8只,HCC组:高脂肪、缺乏胆碱的饮食加致癌物二乙基亚硝胺;肝癌治疗组:高脂肪、缺乏胆碱的饮食加二乙基亚硝胺并给予利福昔明治疗;对照组:标准饮食加水。16周后对大鼠实施安乐死。我们对非酒精性脂肪性肝病的严重程度和癌症分级、肠道和肝脏组织中的基因表达以及粪便微生物群进行了肝脏病理学分析。结果:肝细胞癌组所有动物均有非酒精性脂肪性肝病,并发展为肝细胞癌病变。与肝细胞癌组相比,利福昔明组动物表现出较轻的非酒精性脂肪性肝病(通过非酒精性脂肪性肝病活动评分[NAS]评估)。肝细胞癌和肝细胞癌+利福昔明组均显示小天狼星红评价的纤维化区域。利福昔明组的三只动物没有发生癌变。肠道菌群分析显示,对照组与肝细胞癌组和利福昔明组在多样性和组成上存在差异。在肝细胞癌组和利福昔明组之间鉴定出12个差异丰富的属。利福昔明组肠道紧密连接基因表达降低。结论:在非酒精性脂肪性肝病相关肝细胞癌的啮齿动物模型中,利福昔明降低了非酒精性脂肪性肝病的组织学严重程度和肝细胞癌的发生,可能是通过调节肠道微生物群而独立于肠道通透性标志物。
{"title":"Potential Beneficial Effect of Rifaximin in the Prevention of Hepatocellular Carcinoma through the Modulation of the Microbiota in an Experimental Model of Non-alcoholic Fatty Liver Disease.","authors":"Jéssica Tonin Ferrari, Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Themis Reverbel da Silveira, Carlos Thadeu Schmidt Cerski, Erica Tozawa, Cláudia P Oliveira, Mário Reis Álvares-da-Silva, Carolina Uribe-Cruz","doi":"10.52787/agl.v53i3.329","DOIUrl":"10.52787/agl.v53i3.329","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the effects of rifaximin through microbiota modulation in a model of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease.</p><p><strong>Methods: </strong>Three groups of 8 adult male Sprague-Dawley rats each were divided as follows: the HCC group: rats fed a high-fat and choline-deficient diet plus diethylnitrosamine as a carcinogen, the hepatocellular carcinoma treated group: rats fed a high-fat and choline-deficient diet plus diethylnitrosamine and treated with rifaximin and the control group: animals fed standard diet and water. The rats were euthanized after 16 weeks. We performed analyses of liver pathology for non-alcoholic fatty liver disease severity and cancer grading, gene expression in intestinal and hepatic tissues and fecal microbiota.</p><p><strong>Results: </strong>All animals in the hepatocellular carcinoma group had non-alcoholic fatty liver disease and developed hepatocellular carcinoma lesions. Rifaximin animals showed less intense non-alcoholic fatty liver disease (assessed by non-alcoholic fatty liver disease activity score [NAS]) compared to the hepatocellular carcinoma group. Both the hepatocellular carcinoma and hepatocellular carcinoma + rifaximin groups showed areas of fibrosis as assessed by picrosirius red. Three animals in the rifaximin group did not develop cancerous lesions. Gut microbiota analyses revealed differences in diversity and composition in the control group vs hepatocellular carcinoma and rifaximin groups. Twelve differentially abundant genera were identified between the hepatocellular carcinoma and rifaximin groups. In the rifaximin group, gene expression of intestinal tight junctions decreased.</p><p><strong>Conclusions: </strong>In a rodent model of non-alcoholic fatty liver disease-related hepatocellular carcinoma, rifaximin reduces the histological severity of non-alcoholic fatty liver disease and the occurrence of hepatocellular carcinoma, probably by modulating the gut microbiota independently of markers of intestinal permeability.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"265-282"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Videocapsule Endoscopy as a Diagnostic Tool for Meckel's Diverticulum in Pediatrics: a Case Report]. [视频胶囊内窥镜作为儿科梅克尔憩室的诊断工具:1例报告]。
Q4 Medicine Pub Date : 2023-09-30 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.296
Ana María Acevedo Forero, Adriana Prada-Rey, Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Manuel Alonso Ardila Báez, Cristian Florez-Sarmiento, Jesús David Castillo

Meckel's diverticulum is a common congenital anomaly of the small intestine caused by incomplete obliteration of the omphalomesenteric duct. Most patients are asymptomatic, and the diagnosis is usually made incidentally on imaging studies. The most common symptom is painless rectal bleeding; however, the presentation can be varied. There are different diagnostic tools for symptomatic, among which the most sensitive is Meckel's scan. However, direct visualization is the way to make an accurate diagnosis, which can be done through video capsule endoscopy, a useful tool to clarify the etiology of bleeding in the small intestine.

梅克尔憩室是一种常见的先天性小肠异常,由脐肠管不完全闭塞引起。大多数患者无症状,诊断通常是偶然的影像学检查。最常见的症状是直肠无痛性出血;然而,表现形式可以多种多样。有不同的诊断工具对症状,其中最敏感的是梅克尔扫描。然而,通过视频胶囊内窥镜可以直接看到小肠出血,这是一种明确小肠出血病因的有效工具,可以准确诊断小肠出血。
{"title":"[Videocapsule Endoscopy as a Diagnostic Tool for Meckel's Diverticulum in Pediatrics: a Case Report].","authors":"Ana María Acevedo Forero, Adriana Prada-Rey, Viviana Parra-Izquierdo, Juan Sebastián Frías-Ordoñez, Manuel Alonso Ardila Báez, Cristian Florez-Sarmiento, Jesús David Castillo","doi":"10.52787/agl.v53i3.296","DOIUrl":"10.52787/agl.v53i3.296","url":null,"abstract":"<p><p>Meckel's diverticulum is a common congenital anomaly of the small intestine caused by incomplete obliteration of the omphalomesenteric duct. Most patients are asymptomatic, and the diagnosis is usually made incidentally on imaging studies. The most common symptom is painless rectal bleeding; however, the presentation can be varied. There are different diagnostic tools for symptomatic, among which the most sensitive is Meckel's scan. However, direct visualization is the way to make an accurate diagnosis, which can be done through video capsule endoscopy, a useful tool to clarify the etiology of bleeding in the small intestine.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"314-319"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Big Data y medicina de precisión: una visión general hacia el futuro. 大数据与精准医疗:对未来的展望。
Q4 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.345
Walter Masson
{"title":"Big Data y medicina de precisión: una visión general hacia el futuro.","authors":"Walter Masson","doi":"10.52787/agl.v53i3.345","DOIUrl":"10.52787/agl.v53i3.345","url":null,"abstract":"","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"203-206"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hemostatic Role of TC-325 in Tumor-Related Upper Gastrointestinal Bleeding: Experience in a Tertiary Care Centre]. [TC-325在肿瘤相关上消化道出血中的止血作用:三级护理中心的经验]。
Q4 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.327
Alejandro Marcelo Suárez, Matías Dan Federici, Andrés Esteban Rocca

Introduction: Conventional endoscopic methods have shown poor hemostatic efficacy in the treatment of bleeding esophagogastroduodenal tumors. Recent studies have suggested, on the contrary, a high therapeutic success with the use of TC-325 (Hemospray ® , Cook Medical, Winston-Salem, NC) in this subgroup of patients. Its easy application and its ability to cover a large surface area appear to position it as a promising treatment for this indication, given the diffuse nature of bleeding in this type of lesions.

Objectives: Our primary aim was to evaluate the immediate and 72-hour hemostatic role of TC-325 in patients with upper gastrointestinal bleeding of tumor origin admitted to our institution. Our secondary objective was to analyze their rebleeding rate at one month and complications.

Materials and methods: Retrospective, observational and longitudinal analysis, conducted between March 2018 and May 2022, based on the electronic records of the Digestive Endoscopy Unit of the Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, inpatient medical records and outpatient follow-up records of the Oncology service. We included all patients with upper gastrointestinal tumors with active bleeding verified during upper digestive video endoscopy (UDVE), with data available at least to analyze our primary objective. Clinical, demographic and endoscopic variables were collected, as well as laboratory data, tumor location and bleeding severity.

Results: A total of 21 patients, 81% men, with a mean age of 65 years were included. The most frequent presenting symptom was melena (81%), with gastric location being the most frequent (71.4%), and intestinal adenocarcinoma being the most common histological type. Immediate hemostasis was achieved in 19/21 patients (91%) treated with TC-325. Of the 18 patients who survived to 72 hours, 100% remained free of rebleeding at the end of this period. Furthermore, of the 16 patients alive at 30 days, only 4 (25%) rebleed, which allowed the application of definitive hemostatic treatments in better clinical conditions in 10 of them (3 patients underwent surgery and 7 others received radio and/or chemotherapy). Hemospray treatment was very safe, with no immediate or delayed complications. However, as these patients had locally advanced tumors or disseminated neoplasms, their prognosis was unfavorable, with mortality at 1 and 6 months of 24% and 66% respectively.

Conclusion: Treatment of tumoral upper gastrointestinal bleeding with TC-325 is very effective and safe. Its high rate of immediate and early hemostasis suggests a promising role as a bridging therapy, allowing the subsequent application of more definitive hemostatic treatments. Medium-term mortality remains equally high, given the generally advanced tumor stage.

传统内镜下止血方法治疗食管胃十二指肠出血肿瘤的止血效果较差。最近的研究表明,与此相反,在这一亚组患者中使用TC-325 (hemspray®,Cook Medical, Winston-Salem, NC)取得了很高的治疗成功率。鉴于这种类型病变出血的弥漫性,其易于应用和覆盖大面积的能力似乎使其成为一种有希望的治疗方法。目的:我们的主要目的是评估TC-325在我院收治的肿瘤源性上消化道出血患者的即时和72小时止血作用。我们的次要目的是分析他们一个月的再出血率和并发症。材料和方法:2018年3月至2022年5月,基于Gastroenterología医院Carlos Bonorino Udaondo医生消化内窥镜科的电子记录、肿瘤服务的住院病历和门诊随访记录,进行回顾性、观察性和纵向分析。我们纳入了所有经上消化道视频内窥镜(UDVE)证实有活动性出血的上消化道肿瘤患者,这些数据至少可以分析我们的主要目的。收集临床、人口统计学和内镜变量,以及实验室数据、肿瘤位置和出血严重程度。结果:共纳入21例患者,81%为男性,平均年龄65岁。最常见的症状是黑黑(81%),胃部位最常见(71.4%),肠腺癌是最常见的组织学类型。使用TC-325治疗的21例患者中有19例(91%)实现了立即止血。在存活到72小时的18例患者中,100%在这段时间结束时没有再出血。此外,在30天存活的16例患者中,只有4例(25%)再出血,这使得其中10例患者在较好的临床条件下应用了明确的止血治疗(3例患者接受了手术,另外7例患者接受了放疗和/或化疗)。血液喷雾治疗非常安全,没有立即或延迟的并发症。然而,由于这些患者有局部晚期肿瘤或播散性肿瘤,其预后不利,1个月和6个月的死亡率分别为24%和66%。结论:TC-325治疗肿瘤性上消化道出血安全有效。其高的即时和早期止血率表明,作为桥接治疗的有希望的作用,允许随后应用更明确的止血治疗。由于肿瘤阶段普遍较晚,中期死亡率仍然很高。
{"title":"[Hemostatic Role of TC-325 in Tumor-Related Upper Gastrointestinal Bleeding: Experience in a Tertiary Care Centre].","authors":"Alejandro Marcelo Suárez, Matías Dan Federici, Andrés Esteban Rocca","doi":"10.52787/agl.v53i3.327","DOIUrl":"10.52787/agl.v53i3.327","url":null,"abstract":"<p><strong>Introduction: </strong>Conventional endoscopic methods have shown poor hemostatic efficacy in the treatment of bleeding esophagogastroduodenal tumors. Recent studies have suggested, on the contrary, a high therapeutic success with the use of TC-325 (Hemospray <sup>®</sup> , Cook Medical, Winston-Salem, NC) in this subgroup of patients. Its easy application and its ability to cover a large surface area appear to position it as a promising treatment for this indication, given the diffuse nature of bleeding in this type of lesions.</p><p><strong>Objectives: </strong>Our primary aim was to evaluate the immediate and 72-hour hemostatic role of TC-325 in patients with upper gastrointestinal bleeding of tumor origin admitted to our institution. Our secondary objective was to analyze their rebleeding rate at one month and complications.</p><p><strong>Materials and methods: </strong>Retrospective, observational and longitudinal analysis, conducted between March 2018 and May 2022, based on the electronic records of the Digestive Endoscopy Unit of the Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, inpatient medical records and outpatient follow-up records of the Oncology service. We included all patients with upper gastrointestinal tumors with active bleeding verified during upper digestive video endoscopy (UDVE), with data available at least to analyze our primary objective. Clinical, demographic and endoscopic variables were collected, as well as laboratory data, tumor location and bleeding severity.</p><p><strong>Results: </strong>A total of 21 patients, 81% men, with a mean age of 65 years were included. The most frequent presenting symptom was melena (81%), with gastric location being the most frequent (71.4%), and intestinal adenocarcinoma being the most common histological type. Immediate hemostasis was achieved in 19/21 patients (91%) treated with TC-325. Of the 18 patients who survived to 72 hours, 100% remained free of rebleeding at the end of this period. Furthermore, of the 16 patients alive at 30 days, only 4 (25%) rebleed, which allowed the application of definitive hemostatic treatments in better clinical conditions in 10 of them (3 patients underwent surgery and 7 others received radio and/or chemotherapy). Hemospray treatment was very safe, with no immediate or delayed complications. However, as these patients had locally advanced tumors or disseminated neoplasms, their prognosis was unfavorable, with mortality at 1 and 6 months of 24% and 66% respectively.</p><p><strong>Conclusion: </strong>Treatment of tumoral upper gastrointestinal bleeding with TC-325 is very effective and safe. Its high rate of immediate and early hemostasis suggests a promising role as a bridging therapy, allowing the subsequent application of more definitive hemostatic treatments. Medium-term mortality remains equally high, given the generally advanced tumor stage.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"291-300"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Era of Intelligent Endoscopy: How Artificial Intelligence Empowers Digestive Endoscopy]. [智能内窥镜时代:人工智能如何赋能消化内窥镜]。
Q4 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.339
Jorge Baquerizo-Burgos, María Egas-Izquierdo, Doménica Cunto, Carlos Robles-Medranda

Artificial intelligence is a field of science and engineering that focuses on the computational understanding of intelligent behaviors and the creation of artifacts that exhibit such behaviors, enabling computers to function and think similarly to humans. This technology assists in overcoming the various challenges that healthcare professionals face, contributing to the diagnosis, management, and prognosis of patients. Currently, several artificial intelligence models have been developed in the field of digestive endoscopy, including some that enable the detection of anatomical structures that can aid in the training of medical professionals, serve as guides during endoscopic procedures, or assist in stratifying pre-malignant and malignant lesions. This reduces false negatives, providing timely treatments. Computerized lesion detection and diagnostic system exist for different segments of the digestive tract, each with specific functions that provide assistance during procedures. All of this has been done with the aim of reducing risks stemming from human and environmental factors, among others, which can affect early diagnosis and management of diseases. Artificial intelligence models for digestive endoscopy can not only enhance the visual impression for endoscopists but also reduce the learning curve through the application of precise technologies, thus bridging the gap between experienced and less experienced endoscopists. This article discusses the technological advancements of artificial intelligence in digestive endoscopy and related future aspects.

人工智能是一个科学和工程领域,专注于对智能行为的计算理解和表现这种行为的人工制品的创造,使计算机能够像人类一样运作和思考。这项技术有助于克服医疗保健专业人员面临的各种挑战,有助于患者的诊断、管理和预后。目前,在消化内窥镜领域已经开发了几种人工智能模型,包括一些能够检测解剖结构的模型,这些结构可以帮助培训医疗专业人员,在内窥镜检查过程中充当指导,或协助对恶性前病变和恶性病变进行分层。这减少了假阴性,提供了及时的治疗。计算机病变检测和诊断系统存在于消化道的不同部分,每个部分都有特定的功能,在手术过程中提供帮助。所有这一切都是为了减少可能影响疾病早期诊断和管理的人为因素和环境因素等造成的风险。消化内镜人工智能模型不仅可以增强内镜医师的视觉印象,还可以通过精确技术的应用减少学习曲线,从而弥合经验丰富的内镜医师与经验不足的内镜医师之间的差距。本文讨论了人工智能在消化内窥镜检查中的技术进展及其未来发展方向。
{"title":"[The Era of Intelligent Endoscopy: How Artificial Intelligence Empowers Digestive Endoscopy].","authors":"Jorge Baquerizo-Burgos, María Egas-Izquierdo, Doménica Cunto, Carlos Robles-Medranda","doi":"10.52787/agl.v53i3.339","DOIUrl":"10.52787/agl.v53i3.339","url":null,"abstract":"<p><p>Artificial intelligence is a field of science and engineering that focuses on the computational understanding of intelligent behaviors and the creation of artifacts that exhibit such behaviors, enabling computers to function and think similarly to humans. This technology assists in overcoming the various challenges that healthcare professionals face, contributing to the diagnosis, management, and prognosis of patients. Currently, several artificial intelligence models have been developed in the field of digestive endoscopy, including some that enable the detection of anatomical structures that can aid in the training of medical professionals, serve as guides during endoscopic procedures, or assist in stratifying pre-malignant and malignant lesions. This reduces false negatives, providing timely treatments. Computerized lesion detection and diagnostic system exist for different segments of the digestive tract, each with specific functions that provide assistance during procedures. All of this has been done with the aim of reducing risks stemming from human and environmental factors, among others, which can affect early diagnosis and management of diseases. Artificial intelligence models for digestive endoscopy can not only enhance the visual impression for endoscopists but also reduce the learning curve through the application of precise technologies, thus bridging the gap between experienced and less experienced endoscopists. This article discusses the technological advancements of artificial intelligence in digestive endoscopy and related future aspects.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"211-225"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12120952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Difficult-to-Extract Foreign Bodies in Pediatric Patients]. 【小儿难辨异物】。
Q4 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-07-01 DOI: 10.52787/agl.v53i3.336
Carlos Mario Mendez-Nieto, Lucía Casas-Guzik, Roberto Cervantes-Bustamante, Flora Elva Zárate-Mondragón

The ingestion of foreign bodies is an emergency and one of the accidents with the highest morbidity and mortality in pediatrics. Due to their characteristics and location, some represent a challenge for endoscopic extraction, so it is important to have various accessories and technical skills to achieve extraction. The objective of this article is to present a series of cases of ingestion of difficult-to-extract foreign bodies that required unconventional techniques and that could serve as a guide for the treatment of similar cases.

小儿异物误食是一种急症,是儿科发病率和死亡率最高的意外之一。由于它们的特点和位置,有些对内窥镜摘除来说是一个挑战,因此拥有各种配件和技术技能来实现摘除是很重要的。本文的目的是提出一系列的情况下,难以提取异物,需要非常规的技术,可以作为治疗类似的情况下的指导。
{"title":"[Difficult-to-Extract Foreign Bodies in Pediatric Patients].","authors":"Carlos Mario Mendez-Nieto, Lucía Casas-Guzik, Roberto Cervantes-Bustamante, Flora Elva Zárate-Mondragón","doi":"10.52787/agl.v53i3.336","DOIUrl":"10.52787/agl.v53i3.336","url":null,"abstract":"<p><p>The ingestion of foreign bodies is an emergency and one of the accidents with the highest morbidity and mortality in pediatrics. Due to their characteristics and location, some represent a challenge for endoscopic extraction, so it is important to have various accessories and technical skills to achieve extraction. The objective of this article is to present a series of cases of ingestion of difficult-to-extract foreign bodies that required unconventional techniques and that could serve as a guide for the treatment of similar cases.</p>","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":"53 3","pages":"301-308"},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12500181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145670146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Gastroenterologica Latinoamericana
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1